Abstract:Introduction Influenza A virus (IAV) infection predisposes to subsequent bacterial superinfection in the lungs that promotes a greater pneumonia severity. Among host innate immune players, alveolar macrophages (AM) are essential for lung protection against bacteria. From mice studies, the prominent paradigm suggests that influenza infection induces almost total mouse AM (mAM) depletion, resulting in an increased vulnerability to secondary bacterial infection. Nevertheless, the potential IAV-induced AM depletion as never been study in human. The aim of the study is to characterize the AM number in newly influenza-infected human and to compare the ability of IAV to infect AM from mouse and human origin. Methods Because the observation of AM depletion in mice was described with non-translational influenza inoculum (too high), we infected c57BL/6J mice with a mild inoculum of influenza A virus (H3N2, 10 PFU) by intranasal route and measured the AM count. Next, we described a case report of a hospital-acquired influenza infection in a patient with pre and post-infection bronchoalveolar lavage (BAL) procedures. Then, we extracted data from 2 published clinical investigations assessing BAL in critical care unit and we performed an ancillary study included patients with a PCR-confirmed influenza infection and a BAL performed within the four firth days of ICU admission (AM expressed in mean ± SEM). Finally, using ex vivo AMs models, we compared the ability of IAV to infect mouse and human AMs and the subsequence consequences regarding inflammatory mediator production. Results Using mice model of mild IAV infection, we demonstrated that despite the low IAV inoculum the AM count dropped drastically in the BAL fluid from the fourth day (reduction of 64% from baseline) and was maximal at the seventh day post-infection (reduction of 90%). At the contrary, a patient newly infected by IAV (4 days after the onset of the symptoms) did not present significant modification of the AM count (> 200,000 cells/mL before and after the IAV infection). Next, we assessed the cellularity of BAL of influenza-infected critically ill patients ( n = 15) and controls ( n = 7), thanks to the ancillary study described. The absolute AM count was respectively 3.8 × 10 5 ± 1.5 × 10 5 cells/mL in influenza-infected and 2.8 × 10 5 ± 0.6 × 10 5 cells/mL in controls. In ex vivo AM models, we demonstrated that IAV infects, replicates, and induces inflammatory response similarly in AM of mouse and human origins. Conclusion We demonstrated that IAV-induced AM depletion in mouse but not in human. We did not observe difference in vitro regarding the viral replication and subsequent inflammatory response in mAM and mAM. It is unlikely that the secondary bacterial infections are explained by AM depletion in influenza-infected human.

Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells

Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus

New Insights from an Ex Vivo Model

Influenza A Virus Disruption of Dendritic Cell-Natural Killer Cell Crosstalk Impacts Activation of Helper and Cytotoxic T cell Subsets

Influenza A Infection Stimulates RIG-I and Enhances Effector Function of Primary Human NK Cells

Inhibition of Human Natural Killer Cell Activity by Influenza Virions and Hemagglutinin

Impact of patient characteristics on innate immune responses and inflammasome activation in ex vivo human lung tissues infected with influenza A virus

Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1

Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection

Influenza Virus Directly Infects Human Natural Killer Cells and Induces Cell Apoptosis.

Phenotypic and Functional Characteristics of a Novel Influenza Virus Hemagglutinin-Specific Memory NK Cell

Influenza A virus infection instructs hematopoiesis to megakaryocyte-lineage output

Systemic Infection Ruined Nk Cell-Mediated Help On Influenza Virus-Specific Ctls

Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection

Distinct Kir/Hla Compound Genotypes Affect the Kinetics of Human Antiviral Natural Killer Cell Responses

Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis

Human Mucosal-Associated Invariant T Cells Contribute to Antiviral Influenza Immunity Via Il-18-Dependent Activation

Respiratory Influenza Virus Infection Induces Memory-Like Liver Nk Cells In Mice

Influenza induces depletion of alveolar macrophages in mice but not in human

Differential Activation of NK Cells by Influenza A Pseudotype H5N1 and 1918 and 2009 Pandemic H1N1 Viruses.

Cutting Edge: DNA in the Lung Microenvironment during Influenza Virus Infection Tempers Inflammation by Engaging the DNA Sensor AIM2